Detalhe da pesquisa
1.
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Br J Haematol
; 176(1): 124-130, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748513
2.
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.
Blood Cells Mol Dis
; 51(2): 85-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23628348
3.
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.
Blood
; 116(16): 2875-83, 2010 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20551378
4.
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
Am J Hematol
; 87(7): 732-3, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22622672
5.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Hemoglobin
; 35(3): 206-16, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599433
6.
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition.
Br J Haematol
; 148(3): 476-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19930183
7.
Long-term chelation therapy with deferasirox: effects on cardiac iron overload measured by T2* MRI.
Clin Drug Investig
; 30(4): 267-73, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20225910
8.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Br J Haematol
; 145(2): 245-54, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19236376
9.
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Blood Cells Mol Dis
; 42(3): 247-51, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19233692
10.
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Haematologica
; 93(8): 1243-6, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18556410
11.
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients.
J Cardiovasc Med (Hagerstown)
; 16(10): 689-95, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26090920